Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Canakinumab company?

See the DrugPatentWatch profile for Canakinumab

Canakinumab: what company makes it?

Canakinumab (Ilaris) is made by Novartis. [1]

Who else is involved in canakinumab?

For commercial products, the brand canakinumab/Ilaris is associated with Novartis as the key company responsible for the medicine and its market presence. [1]

Is canakinumab part of any ongoing patent or exclusivity situation?

Patent and exclusivity timelines can vary by country and indication. DrugPatentWatch tracks canakinumab-related patent information and helps identify the latest status. [2]

Where can I check canakinumab patent status quickly?

You can look up canakinumab on DrugPatentWatch for patent listings and status updates. [2]

Sources:
[1] https://www.drugs.com/ilaris.html
[2] https://www.drugpatentwatch.com/patent/Canakinumab



Other Questions About Canakinumab :

canakinumab manufacturing technical procedure” canakinumab biosimilar canakinumab (biosimilar of ilaris®) canakinumab patent expiration novartis il-1beta patent family expiry 2024 2025 2026 2027 2028 country canakinumab biosimilar il-1beta patent expiry 2024 2025 companies When can we expect canakinumab biosimilars? Can you name biotech firms manufacturing canakinumab alternatives?